Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Revenue (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Revenue for 2 consecutive years, with $16000.0 as the latest value for Q3 2025.

  • Quarterly Revenue fell 98.69% to $16000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $64000.0 through Dec 2025, down 99.75% year-over-year, with the annual reading at $64000.0 for FY2025, 99.75% down from the prior year.
  • Revenue hit $16000.0 in Q3 2025 for Connect Biopharma Holdings, down from $48000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $24.1 million in Q2 2024 to a low of $16000.0 in Q3 2025.